Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Roche, Lonza Enter Assay Distribution Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Roche, Lonza Enter Assay Distribution Pact

Roche and Lonza have entered into a distribution agreement for the commercialization of Roche’s MycoTOOL mycoplasma PCR assays.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roche and Lonza have entered into a distribution agreement for the commercialization of Roche’s MycoTOOL mycoplasma PCR assays. MycoTOOL detection kits are now available through Lonza for final release testing of pharmaceutical products, upon validation. Lonza also offers contract testing services using the MycoTOOL test, which is a commercial NAT-based detection system for mycoplasma biosafety testing of approved biologics.

Robert Yates, head of Roche Applied Science, said, “Lonza’s reputation for quality and customer care gives us confidence that MycoTOOL will be placed in the right applications for customers who wish to perform rapid mycoplasma testing in-house, and for those who prefer to send their samples to a qualified outside laboratory for testing.”

“Roche and Lonza share the rare combination of being both consumers and providers of pharmaceutical quality control and diagnostics products. This internal integration of user and manufacturer helps ensure products align properly with user requirements and capabilities. The unique perspective of being a user of the very products you sell provides insight unattainable from the outside looking in. We are pleased to be working with Roche in bringing this advancement to our colleagues,” said Lukas Utiger, head of Lonza BioSciences.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics